Winner's Circle
Young investigators at universities and research institutes in the United States and Canada with innovative projects and promising careers in pulmonary vascular disease have been supported by the ATS Early Career Investigator Award in Pulmonary Vascular Disease program since 2005. Click on the links to the right for details about prior winners.
YOUNG INVESTIGATORS’ ATS EARLY CAREER INVESTIGATOR AWARD IN PULMONARY VASCULAR DISEASE-FUNDED SCIENTIFIC POSTERS
Pulmonary Hypertension Associated with Congenital Heart Disease: Translating Natural History into Pathobiology
YI (2017): Rebecca Kameny, MD
Year of Scientific Poster: 2018
Poster
Evidence of Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension
YI (2014): Evan L. Brittain, MD, MSCI
Year of Scientific Poster: 2016
Poster
Reduced CFlm25 Expression as a Regulator of Pulmonary Hypertension Through HAS2
YI (2013): Harry Karmouty-Quintana, PhD
Year of Scientific Poster: 2016
Poster
Aortic Wall Shear Stress and Left Ventricular Systolic Performance are Reduced in Pediatric Patients with Pulmonary Arterial Hypertension
YI (2015): Uyen T. Truong, MD
Year of Scientific Poster: 2016
Poster
Increased Hyaluronan and Altered Lymphangiogenesis in Group III Pulmonary Hypertension
YI (2013): Harry Karmouty-Quintana, PhD
Year of Scientific Poster: 2015
Poster
Hypoxic-SUGEN Rat Model of Pulmonary Hypertension Induces Proteome Changes to Visceral Adipose
YI (2012): Kelly J. Shields, PhD
Year of Scientific Poster: 2014
Poster
Hyaluronan and the development of Pulmonary Hypertension Secondary to Lung Fibrosis
YI (2013): Harry Karmouty-Quintana, PhD
Year of Scientific Poster: 2014
Poster
Increased Glutamine Metabolism is a Key Feature of the Metabolic Reprogramming in BMPR2 Mutant Pulmonary Endothelium
YI (2012): Joshua P. Fessel, MD, PhD
Year of Scientific Poster: 2013
Poster
Osteopontin Lung Expression is a Marker of Disease Severity in Pulmonary Arterial Hypertension
YI (2011): Marco Mura, MD, PhD
Year of Scientific Poster: 2013
Poster
Hospital Admission Volume Predicts 30-Day Readmission in Pulmonary Arterial Hypertension
YI (2009): Alexander R. Opotowsky, MD, MPH
Year of Scientific Poster: 2013
Poster
Targeting the MetAP2 Pathway in Pulmonary Arterial Hypertension
YI (2009): Daniel J. Kass, MD
Poster data published, PLoS ONE 2012
Poster
Acute Hypoxic Pulmonary Artery Responses in the WKY and BN Rodent Strains
YI (2011): Salah Najm, MD
Year of Scientific Poster: 2012
Poster
BMP9 Regulates Endothelin-1 Gene Transcription in Cooperation with TGFβ Signaling
YI (2011): Jana Bagarova, PhD
Year of Scientific Poster: 2011
Poster
A New, More Effective Combination Therapy for Pulmonary Arterial Hypertension: Bosentan and VIP
YI (2008): Sayyed A. Hamidi, MD
Year of Scientific Poster: 2010
Poster
Bosentan Attenuates Severe Occlusive Pulmonary Hypertension in Rats – Role of Endothelin Receptors Signaling
YI (2007): Olga Rafikova, MD, PhD
Year of Scientific Poster: 2010
Poster
Endothelin-1-Rho-kinase Interactions Impair Angiogenesis in Fetal Pulmonary Artery Endothelial Cells after Chronic Intrauterine Pulmonary Hypertension
YI (2010): Jason Gien, MD
Year of Scientific Poster: 2010
Poster
Role of Endothelial – Mesenchymal Transition in the Development of Pulmonary Hypertension
YI (2008): Ari L. Zaiman, MD, PhD
Year of Scientific Poster: 2010
Poster
Apelin Deficient Mice Demonstrate Worsening Pulmonary Hypertension in Nitric Oxide Dependent Manner
YI (2008): Hyung J. Chun, MD
Year of Scientific Poster: 2009
Poster
